InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Bejar Rafael, Directeur Médical. Director active across 1 companies, notably Aptose Biosciences Inc.. In total, 2 disclosures have been logged. Total volume traded: €45k. The latest transaction was disclosed on 19 November 2021 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€22,51910,000 shares@ €2.25190.57% mcap100.0% of flow
Common Shares
SEC:0001567619-21-020906·
Ideal exit: 16 Aug 2022 (T+270)
€22,51910,000 shares@ €2.25190.57% mcap50.0% of flow
Common Shares
SEC:0001567619-21-020906:0·
Ideal exit: 16 Aug 2022 (T+270)
2 of 2 declarations
About Bejar Rafael
Rafael Bejar is the Chief Medical Officer at Aptose Biosciences Inc. He is responsible for the medical and scientific direction of the company, overseeing the development of new treatments and clinical research. His expertise in medicine and biotechnology is crucial for the innovation and success of the company. Rafael is committed to improving patient outcomes.
